Top NYC, NY AI Companies With Best Stability & Growth (941)

Strong Revenue Growth: Feedback suggests revenue accelerated in Q1 2026 to above $1B with year‑over‑year growth, and guidance for Q2 and full‑year 2026 points to continued expansion. Management highlighted momentum from larger customers and pipeline confidence into the next quarter.

Healthy Cash Flow: Feedback suggests operating cash flow and free cash flow were robust in Q1 2026 and throughout 2025, supporting growth while preserving liquidity. The company reported strong cash generation alongside positive non‑GAAP margins.

Product Line Growth: Feedback suggests expanding platform breadth across observability, security, and AI is driving deeper adoption and upsell. New capabilities launched in Q1 2026 (e.g., GPU Monitoring, Bits AI Security Analyst, MCP Server) underscore ongoing product expansion.

Profitability: Reported operating earnings reached $3.6 billion in 2025, a 4% increase over 2024, with the company citing record results in both 2024 and 2025. This upward trend indicates expanding earnings power.

Investor Backing & Capital Strength: Surplus grew to $34.7 billion in 2025 (from $33.3 billion in 2024) alongside continued highest-tier financial strength ratings and record policyowner dividends. These signals point to a robust capital base supporting obligations and growth capacity.

Product Line Growth: Insurance sales rose 14% and annuity sales 40% in 2025, and individual life insurance in force climbed to nearly $1.3 trillion. Such broad-based product momentum underpins expansion across core franchises.

Strong Revenue Growth: Multiple signals, including multi‑year FT1000 recognition, recent regional gains, and directionally consistent third‑party revenue scale estimates, indicate sustained expansion. Materials suggest growth continues even if the pace is more measured than earlier years.

Product Line Growth: The launch of a self‑serve platform (rtb.com) and continued moves beyond core enterprise retargeting broaden the offering and expand the addressable market. Evidence points to ongoing product expansion aimed at new customer segments.

Future-Ready Strategy: Active testing and implementation around Chrome’s Privacy Sandbox and participation in industry ecosystems (e.g., Prebid, IAB Tech Lab) show preparation for post‑third‑party‑cookie dynamics. This positioning is presented as a medium‑term growth enabler.

Strong Revenue Growth: Evidence indicates strong year-over-year expansion in 2024 with subsequent signals pointing to continued growth into 2025–2026. Company communications and third-party coverage consistently describe sustained momentum from 2024 onward.

Investor Backing & Capital Strength: Reports describe a sizable January 2025 secondary transaction that increased valuation, indicating strong investor demand and liquidity. Commentary also notes preparation for a potential listing, suggesting access to capital as market conditions permit.

Innovation-Driven Growth: Coverage highlights rollout of identity and AI-led capabilities and the integration of CDP functionality via the mParticle deal, expanding the product surface for enterprise ecommerce. Announced partnerships such as a PayPal ecosystem integration and ongoing network-scale updates suggest innovation translating to adoption.

Strong Revenue Growth: Reported year-over-year revenue growth culminating in a substantial revenue run‑rate by early 2026 indicates accelerating top‑line momentum.

Investor Backing & Capital Strength: A large late‑2025 funding round at a significantly higher valuation provides fresh capital and signals confidence in continued scaling.

Strong Market Position & Advantage: Placement as a “Leader” in a 2026 Cloud PaaS grid and rising peak‑period platform load point to strong customer presence and competitive standing.

Innovation-Driven Growth: Recent launches at X4 2026, including AI-driven Experience Agents and synthetic research tools, reflect active product investment aimed at increasing adoption and wallet share. AI enablement across the platform and related certifications underscore ongoing product acceleration.

Market Expansion: The Press Ganey Forsta acquisition, announced in 2025 and closed in May 2026, broadened the healthcare experience footprint and added significant data assets. This move aligns with an aggressive scale-up strategy in a high-demand vertical.

Future-Ready Strategy: Achieving ISO/IEC 42001:2023 and FedRAMP High for AI capabilities, alongside a clear focus on regulated sectors like healthcare, signals enterprise readiness. These milestones support expansion into public sector and other compliance-sensitive markets.

Strong Revenue Growth: Multiple reports cite record net trading revenues through late 2025 and into Q1 2026 (including a sharp year‑on‑year surge), indicating accelerating top‑line performance. These results are presented as consecutive records, suggesting strong momentum into this year.

Market Expansion: The firm lists 14 offices across North America, Europe, and Asia-Pacific and has added regional leadership in Asia, pointing to an expanding geographic footprint. Ongoing hiring activity across technical and trading infrastructure roles further aligns with capacity scale‑up.

Diversified Revenue Streams: Operations span multiple asset classes and channels, including equities, futures, options, currencies, fixed income, crypto, and U.S. retail equity wholesaling. This breadth indicates revenue sources are not confined to a single product or venue.

Strong Revenue Growth: Recent results show Q1 2026 revenue of about $1.53B, up 12% year over year, with full‑year 2025 up 11%. Management highlighted improved ad performance and margin expansion alongside this top‑line momentum.

Diversified Revenue Streams: Snapchat+ surpassed 25 million subscribers and direct revenue reached roughly a $1B annualized run rate, signaling traction beyond advertising. Other Revenue grew sharply in early 2026, reinforcing diversification progress.

Healthy Cash Flow: Adjusted EBITDA more than doubled to $233M in Q1 2026 and Free Cash Flow rose to $286M, indicating stronger cash generation. Net losses narrowed meaningfully as operating throughput improved.

Investor Backing & Capital Strength: A $31M Series B in February 2026 led by FPV Ventures with participation from Vertex Ventures, ADP Ventures, Y Combinator, and Restive Ventures signals strong investor confidence and ample capital. Total reported funding around $46M alongside the rebrand provides runway to scale platform and operations.

Market Expansion: Funding is explicitly earmarked to expand beyond R&D tax credits into 179D and cost segregation and further into additional U.S. tax/accounting workflows. Public materials also reference plans to broaden financial/compliance automation and geographic reach through 2026.

Strong Hiring & Retention: The Greenhouse careers page lists about 10 open roles across sales, marketing, and client success, typical of go‑to‑market expansion. The LinkedIn footprint shows an active presence in the 51–200 employee range following the rebrand.

Strong Revenue Growth: Reported and organic revenue increased in 2025 and accelerated into early 2026, with margins expanding. Q1 2026 showed re‑accelerated momentum supported by multiple engines.

Profitability: Adjusted operating income and margins expanded in 2025 and improved further in Q1 2026. Results show stronger profitability alongside revenue gains.

Diversified Revenue Streams: Multiple businesses—Morningstar Credit, the Morningstar Direct Platform (Data and Direct), PitchBook, and Retirement—drove broad‑based growth. Credit benefited from robust issuance across geographies and asset classes while platforms and data added steady subscription‑led expansion.

Investor Backing & Capital Strength: Recent announcements cite a $23M Series A extension in May 2025, bringing total disclosed funding to about $60M from investors including Kleiner Perkins, Greenoaks, Meritech, and Spark. These capital signals are described as fueling headcount growth, product development, and go‑to‑market execution.

Innovation-Driven Growth: Product momentum is shown by the 2025 pivot to the Clark AI agent and the “Superblocks 2.0” platform update in April 2026, alongside ongoing release notes through 2026. These launches indicate continued investment in AI, governance, and platform capabilities.

Strong Hiring & Retention: Company materials and listings show open roles and recent postings as of June 2026. This activity suggests headcount expansion rather than contraction.

Investor Backing & Capital Strength: Recent funding rounds, including a $40M Series B in late 2025 following a 2024 round, indicate strong capital support to scale. Coverage also notes planned headcount growth in 2026 aligned with this investment trajectory.

Market Expansion: A June 2026 integration to run Meta Partnership Ads across Instagram and Facebook marks expansion beyond the company’s original YouTube focus. Early beta indications of higher ROAS and broader channel coverage suggest traction in new platforms.

Strong Revenue Growth: Materials describe rapid year-over-year growth with significant advertiser spend shifting onto the platform. Named brand case studies and growing campaign volume point to scaling commercial activity.

Strong Market Position & Advantage: Independent analyst firms repeatedly place Collibra in the Leader tier (Gartner 2025–2026; Forrester 2023/2025; IDC 2024; BARC 2026), and it is widely adopted by large enterprises including many Fortune 500 organizations. This sustained recognition and customer footprint indicate durable competitive advantage.

Innovation-Driven Growth: The platform expanded into AI governance with general availability in 2024 and launched AI-first features like Copilot and the AI Command Center in 2026, while acquiring Raito and Deasy Labs to extend access and unstructured data governance. These moves show a deliberate push to grow product scope and align to emerging AI needs.

Strategic Partnerships: Ecosystem traction includes awards and deeper alliances, such as Databricks’ Governance Partner of the Year (2026) and Google Cloud Partner of the Year for Governance, alongside expanded Snowflake integrations. These partnerships amplify market reach and reinforce platform relevance across major data clouds.

Strategic Partnerships: Recent distribution via a benefits platform (StretchDollar) places the service inside employer channels, signaling expanded go‑to‑market reach. Public partner materials indicate the advocacy service is being offered as an employer perk, broadening access beyond direct-to-consumer.

Investor Backing & Capital Strength: A 2024 Form D filing under the prior legal name and references to a significant seed raise indicate fresh capital to support scaling. The filing signed by the CEO points to formal fundraising intended to fuel growth initiatives.

Market Expansion: Company materials now market consumer outcomes and claim broad family trust, suggesting increased reach since the rebrand. Coverage in a major newspaper feature on using chatbots to fight medical bills elevated visibility in the core problem space.

Product Line Growth: Evidence indicates non‑COVID brands and newly launched/acquired assets are expanding, with growth led by Eliquis, Vyndaqel/Vyndamax, oncology biosimilars, Nurtec, and Seagen‑originated therapies such as Padcev.

Future-Ready Strategy: Company materials highlight the Seagen acquisition as a multi‑year oncology growth engine alongside recent approvals and advancing vaccine programs, with numerous pivotal starts planned to add future contributors.

Cost & Operational Efficiency: Disclosures describe a multi‑year cost realignment targeting substantial net savings, alongside deleveraging priorities and expected integration synergies to support margin stability during the revenue mix shift.

Product Line Growth: Product launches such as expanded Cedar Intelligence for billing, the Kora AI voice agent, and affordability tools indicate a steady cadence of feature expansion. These additions broaden use cases from post‑visit billing into coverage, affordability, and automated support.

Market Expansion: New deployments and marketplace integrations (e.g., health‑system wins, ambulatory channels, and marketplace distribution) show expanding reach across health systems, medical groups, and practices. Such channels open growth vectors beyond large enterprise hospital deals.

Strategic Partnerships: Partnerships and ecosystem collaborations (e.g., marketplace integrations and communications platforms) support scale and adoption. An acquisition expanding payer–provider workflows further extends platform breadth and go‑to‑market leverage.

Market Expansion: Public materials indicate the network has expanded to 6,000+ research sites across 50+ countries and 25+ sponsors, up from 5,500+ sites cited in late 2025. This footprint growth signals broader geographic reach and increasing demand-side participation.

Strategic Partnerships: Announced partnerships such as the September 2025 RealTime eClinical data-integration open access to 50+ large site networks (2,000+ sites) and enrich marketplace data. Additional integrations (e.g., eClinPro in 2026) reinforce distribution and embed the platform more deeply in site workflows.

Innovation-Driven Growth: The company launched AI-enabled pre-screening, AI site selection, and EHR integration in 2025–2026 to improve patient identification and sponsor decision-making. These capabilities can increase conversion and make the platform more attractive to both sites and sponsors.

Investor Backing & Capital Strength: Recent financing rounds, including a sizable Series B and an additional credit facility, indicate strong investor confidence and ample runway. The capital is explicitly tied to hiring, go‑to‑market, and product expansion plans across 2024–2026 communications.

Product Line Growth: Ongoing launches such as AI‑powered Claims Analytics and “Zoe for HR” suggest continued investment in expanding the platform. Added capabilities like a cash‑pay network and pharmacy‑related tools point to a broadened offering beyond core navigation.

Strategic Partnerships: Partnerships with platforms and channels such as TriNet, Workday Wellness, PrismHR, and benefit alliances indicate growing distribution reach. Event participation and partner documentation suggest active customer acquisition across employer and PEO ecosystems.

Strong Revenue Growth: ARR milestones rising from $100M in early 2024 to $200M by January 2026 indicate rapid top-line expansion. External recognition such as Deloitte’s Technology Fast 500 placements aligns with a multi‑year growth trajectory.

Investor Backing & Capital Strength: A $100 million Series E at a $1.6 billion valuation signals strong investor confidence. This capital provides fuel for continued product development and go‑to‑market expansion.

Market Expansion: International growth is evidenced by new offices in London and Sydney and the signing of the company’s largest customer in Germany. Reported customer counts moving from 2,600+ to 3,500+ teams suggest widening global adoption.

Product Line Growth: The company launched a unified platform in October 2024 and reported its Contextual product line had grown over 100% year over year, signaling strong product momentum. Case studies and active brand campaigns indicate ongoing utilization of contextual and attention offerings.

Market Expansion: Trade coverage identified Australia as a “real growth market” in 2026 and the company announced expansion into France, pointing to continued international scaling. Earlier milestones such as surpassing $1B in advertiser spend underscore commercial reach.

Future-Ready Strategy: Advertisers increasingly leaning into privacy‑forward contextual and attention strategies in 2025–2026 align with the firm’s core capabilities. Google’s evolving cookie deprecation and Privacy Sandbox timeline create tailwinds for contextual demand even as measurement evolves.